The Latest Kid on the Block: SGLT2 Inhibitors
Presented by Radica Alicic, MD, FHM, FACP
Faculty Hospitalist, Sacred Heart Medical Center; Clinical Faculty for Internal Medicine Residency Spokane; Associate Director for Clinical Research, Providence Medical Research Center.
At the end of this live educational session, participants should be able to:
- Explain the mechanism of action of sodium glucose co-transporter 2 (SGLT2) inhibitors class of antidiabetic medications
- Discuss Cardio Vascular Outcomes (CVO) trials results
- Describe the effects of this class of antidiabetic medications (SLT2 inhibitors) beyond the blood sugar control
101 W. 8th Avenue, Lower Level 3 (near the Cafeteria)